Stromal fibroblast in age-related cancer: Role in tumorigenesis and potential as novel therapeutic target

Frontiers in Oncology

Volumn 5, Issue JUL, 2015, Pages

  Elkhattouti, Abdelouahid ^a   Hassan, Mohamed ^a   Gomez, Christian R ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Carcinogenesis; Microenvironment; ROS; SASP; Senescence; Senescent fibroblasts; Stem cells

Indexed keywords

EID: 84934277521     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00158     Document Type: Article

References (68)

1. Effros RB. Genetic alterations in the ageing immune system: impact on infection and cancer. Mech Ageing Dev (2003) 124(1):71-7. PubMed PMID: 12618008.
2. Smith SK, Kipling D. The role of replicative senescence in cancer and human ageing: utility (or otherwise) of murine models. Cytogenetic and genome research (2004) 105(2-4):455-63. Epub 2004/07/09. doi: 10.1159/000078219. PubMed PMID: 15237234.
3. Hoare M, Narita M. Transmitting senescence to the cell neighbourhood. Nature cell biology (2013) 15(8):887-9. Epub 2013/08/03. doi: 10.1038/ncb2811. PubMed PMID: 23907191.
4. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. The Journal of clinical investigation (2013) 123(3):966-72. Epub 2013/03/05. doi: 10.1172/JCI64098. PubMed PMID: 23454759; PubMed Central PMCID: PMC3582125.
5. Zieske JD, Mason VS, Wasson ME, Meunier SF, Nolte CJ, Fukai N, et al. Basement membrane assembly and differentiation of cultured corneal cells: importance of culture environment and endothelial cell interaction. Experimental cell research (1994) 214(2):621- 33. Epub 1994/10/01. doi: 10.1006/excr.1994.1300. PubMed PMID: 7523155.
6. Yang W, Han W, Ye S, Liu D, Wu J, Liu H, et al. Fibroblast activation protein-alpha promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms. Experimental and molecular pathology (2013) 95(1):105-10. Epub 2013/06/20. doi: 10.1016/j.yexmp.2013.06.007. PubMed PMID: 23778090.
7. Sung SY, Hsieh CL, Wu D, Chung LW, Johnstone PA. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Current problems in cancer (2007) 31(2):36-100. Epub 2007/03/17. doi: 10.1016/j.currproblcancer.2006.12.002. PubMed PMID: 17362788.
8. Schiavoni G, Gabriele L, Mattei F. The tumor microenvironment: a pitch for multiple players. Front Oncol (2013) 3:90. Epub 2013/04/26. doi: 10.3389/fonc.2013.00090. PubMed PMID: 23616948; PubMed Central PMCID: PMC3628362.
9. Bhome R, Bullock MD, Al Saihati HA, Goh RW, Primrose JN, Sayan AE, et al. A top-down view of the tumor microenvironment: structure, cells and signaling. Frontiers in cell and developmental biology (2015) 3:33. Epub 2015/06/16. doi: 10.3389/fcell.2015.00033. PubMed PMID: 26075202; PubMed Central PMCID: PMC4448519.
10. Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends in cell biology (2015) 25(4):198-213. Epub 2014/12/30. doi: 10.1016/j.tcb.2014.11.006. PubMed PMID: 25540894.
11. Goubran HA, Kotb RR, Stakiw J, Emara ME, Burnouf T. Regulation of tumor growth and metastasis: the role of tumor microenvironment. Cancer growth and metastasis (2014) 7:9- 18. Epub 2014/06/14. doi: 10.4137/CGM.S11285. PubMed PMID: 24926201; PubMed Central PMCID: PMC4051818.
12. Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Seminars in cancer biology (2011) 21(1):35-43. Epub 2010/10/16. doi: 10.1016/j.semcancer.2010.10.007. PubMed PMID: 20946957; PubMed Central PMCID: PMC3050428.
13. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nature reviews Cancer (2012) 12(4):298-306. Epub 2012/03/16. doi: 10.1038/nrc3245. PubMed PMID: 22419253.
14. Sznurkowski JJ, Zawrocki A, Biernat W. Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma. Cancer Immunol Immunother (2013). Epub 2013/12/26. doi: 10.1007/s00262-013-1511-x. PubMed PMID: 24368339.
15. Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology (2013) 218(11):1402-10. Epub 2013/07/31. doi: 10.1016/j.imbio.2013.06.003. PubMed PMID: 23891329.
16. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature reviews (2009) 9(3):162-74. Epub 2009/02/07. doi: 10.1038/nri2506. PubMed PMID: 19197294; PubMed Central PMCID: PMC2828349.
17. Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C. Stroma in breast development and disease. Seminars in cell & developmental biology (2010) 21(1):11-8. Epub 2009/10/28. doi: 10.1016/j.semcdb.2009.10.003. PubMed PMID: 19857593; PubMed Central PMCID: PMC2823823.
18. Chen JH, Stoeber K, Kingsbury S, Ozanne SE, Williams GH, Hales CN. Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J Biol Chem (2004) 279(47):49439-46. Epub 2004/09/21. doi: 10.1074/jbc.M409153200. PubMed PMID: 15377661.
19. Stein GH, Drullinger LF, Robetorye RS, Pereira-Smith OM, Smith JR. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc Natl Acad Sci U S A (1991) 88(24):11012-6. Epub 1991/12/15. PubMed PMID: 1722313; PubMed Central PMCID: PMC53063.
20. van Deursen JM. The role of senescent cells in ageing. Nature (2014) 509(7501):439-46. Epub 2014/05/23. doi: 10.1038/nature13193. PubMed PMID: 24848057; PubMed Central PMCID: PMC4214092.
21. Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology (2014) 30(1):16-22. Epub 2013/11/14. doi: 10.3109/09513590.2013.852531. PubMed PMID: 24219599.
22. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 908:244-54. PubMed PMID: 10911963.
23. Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology (2015). Epub 2015/04/30. doi: 10.1007/s10522-015- 9578-8. PubMed PMID: 25921609.
24. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 133(6):1006-18. Epub 2008/06/17. doi: 10.1016/j.cell.2008.03.038. PubMed PMID: 18555777.
25. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 133(6):1019-31. Epub 2008/06/17. doi: 10.1016/j.cell.2008.03.039. PubMed PMID: 18555778.
26. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A (2001) 98(21):12072-7. Epub 2001/10/11. doi: 10.1073/pnas.211053698. PubMed PMID: 11593017; PubMed Central PMCID: PMC59769.
27. Lisanti MP, Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A, et al. Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine. Cell Cycle (2011) 10(13):2059-63. Epub 2011/06/10. PubMed PMID: 21654190; PubMed Central PMCID: PMC3154359.
28. Treiber N, Maity P, Singh K, Kohn M, Keist AF, Ferchiu F, et al. Accelerated aging phenotype in mice with conditional deficiency for mitochondrial superoxide dismutase in the connective tissue. Aging cell (2011) 10(2):239-54. Epub 2010/11/27. doi: 10.1111/j.1474- 9726.2010.00658.x. PubMed PMID: 21108731.
29. Fiaschi T, Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. International journal of cell biology (2012) 2012:762825. Epub 2012/06/06. doi: 10.1155/2012/762825. PubMed PMID: 22666258; PubMed Central PMCID: PMC3361160.
30. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle (2010) 9(17):3485-505. Epub 2010/09/24. doi: 10.4161/cc.9.17.12721. PubMed PMID: 20861672; PubMed Central PMCID: PMC3047615.
31. Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. The international journal of biochemistry & cell biology (2011) 43(7):1045-51. Epub 2011/02/09. doi: 10.1016/j.biocel.2011.01.023. PubMed PMID: 21300172; PubMed Central PMCID: PMC3102770.
32. Balliet RM, Capparelli C, Guido C, Pestell TG, Martinez-Outschoorn UE, Lin Z, et al. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection. Cell Cycle (2011) 10(23):4065-73. Epub 2011/12/02. doi: 10.4161/cc.10.23.18254. PubMed PMID: 22129993; PubMed Central PMCID: PMC3272288.
33. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle (2010) 9(17):3515-33. Epub 2010/09/22. PubMed PMID: 20855962; PubMed Central PMCID: PMC3047617.
34. Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, Pestell RG, et al. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell Cycle (2011) 10(15):2440-9. Epub 2011/07/08. PubMed PMID: 21734470; PubMed Central PMCID: PMC3180186.
35. Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, et al. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkappaB target stromal MCT4. Cell Cycle (2013) 12(16):2580-97. Epub 2013/07/19. doi: 10.4161/cc.25510. PubMed PMID: 23860378.
36. Salotti J, Dias MH, Koga MM, Armelin HA. Fibroblast growth factor 2 causes G2/M cell cycle arrest in ras-driven tumor cells through a Src-dependent pathway. PloS one (2013) 8(8):e72582. Epub 2013/08/31. doi: 10.1371/journal.pone.0072582. PubMed PMID: 23991123; PubMed Central PMCID: PMC3753234.
37. Shan W, Yang G, Liu J. The inflammatory network: bridging senescent stroma and epithelial tumorigenesis. Frontiers in bioscience (2009) 14:4044-57. Epub 2009/03/11. PubMed PMID: 19273333; PubMed Central PMCID: PMC2858971.
38. Kirkwood TB, Austad SN. Why do we age? Nature (2000) 408(6809):233-8. Epub 2000/11/23. doi: 10.1038/35041682. PubMed PMID: 11089980.
39. Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Transactions of the American Clinical and Climatological Association (2006) 117:147-55; discussion 55-6. Epub 2008/06/06. PubMed PMID: 18528470; PubMed Central PMCID: PMC1500929.
40. Das AM, Seynhaeve AL, Rens JA, Vermeulen CE, Koning GA, Eggermont AM, et al. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration. Angiogenesis (2013). Epub 2013/11/14. doi: 10.1007/s10456-013-9385-2. PubMed PMID: 24221409.
41. Lahteenvuo J, Rosenzweig A. Effects of aging on angiogenesis. Circulation research (2012) 110(9):1252-64. Epub 2012/04/28. doi: 10.1161/CIRCRESAHA.111.246116. PubMed PMID: 22539758.
42. Kerkar SP, Muranski P, Kaiser A, Boni A, Sanchez-Perez L, Yu Z, et al. Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts. Cancer research (2010) 70(17):6725-34. Epub 2010/07/22. doi: 10.1158/0008- 5472.CAN-10-0735. PubMed PMID: 20647327; PubMed Central PMCID: PMC2935308.
43. Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, et al. Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Molecular therapy: the journal of the American Society of Gene Therapy (2013) 21(7):1369-77. Epub 2013/04/10. doi: 10.1038/mt.2013.58. PubMed PMID: 23568260; PubMed Central PMCID: PMC3702103.
44. Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother (2014) 63(5):419-35. Epub 2014/02/12. doi: 10.1007/s00262-014-1523-1. PubMed PMID: 24514955; PubMed Central PMCID: PMC3994286.
45. Wiestner A. Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program (2012) 2012:88-96. Epub 2012/12/13. doi: 10.1182/asheducation-2012.1.88. PubMed PMID: 23233565.
46. Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, Keating MJ, et al. The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood (2011) 118(13):3603-12. Epub 2011/08/02. doi: 10.1182/blood-2011-05-352492. PubMed PMID: 21803855.
47. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle (2011) 10(23):4047-64. Epub 2011/12/03. doi: 10.4161/cc.10.23.18151. PubMed PMID: 22134189; PubMed Central PMCID: PMC3272287.
48. Flurkey K, Astle CM, Harrison DE. Life extension by diet restriction and N-acetyl-Lcysteine in genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci (2010) 65(12):1275-84. Epub 2010/09/08. doi: 10.1093/gerona/glq155. PubMed PMID: 20819793; PubMed Central PMCID: PMC2990268.
49. Sampson N, Berger P, Zenzmaier C. Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease. Oxidative medicine and cellular longevity (2012) 2012:458276. Epub 2012/11/15. doi: 10.1155/2012/458276. PubMed PMID: 23150749; PubMed Central PMCID: PMC3486436.
50. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nature reviews Cancer (2010) 10(6):415-24. Epub 2010/05/25. doi: 10.1038/nrc2853. PubMed PMID: 20495575.
51. Sampson N, Koziel R, Zenzmaier C, Bubendorf L, Plas E, Jansen-Durr P, et al. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol Endocrinol (2011) 25(3):503-15. Epub 2011/01/29. doi: 10.1210/me.2010-0340. PubMed PMID: 21273445.
52. Chen YC, Prabhu KS, Das A, Mastro AM. Dietary selenium supplementation modifies breast tumor growth and metastasis. International journal of cancer (2013) 133(9):2054-64. Epub 2013/04/25. doi: 10.1002/ijc.28224. PubMed PMID: 23613334.
53. Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, et al. Selenium for preventing cancer. The Cochrane database of systematic reviews (2014) 3:CD005195. Epub 2014/04/01. doi: 10.1002/14651858.CD005195.pub3. PubMed PMID: 24683040.
54. Pallavi R, Giorgio M, Pelicci PG. Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life. Frontiers in physiology (2012) 3:318. Epub 2012/08/31. doi: 10.3389/fphys.2012.00318. PubMed PMID: 22934068; PubMed Central PMCID: PMC3429088.
55. Lee SH, Min KJ. Caloric restriction and its mimetics. BMB Rep (2013) 46(4):181-7. Epub 2013/04/26. PubMed PMID: 23615258.
56. Blagosklonny MV. Rapamycin extends life- and health span because it slows aging. Aging (2013) 5(8):592-8. Epub 2013/08/13. PubMed PMID: 23934728; PubMed Central PMCID: PMC3796212.
57. Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American journal of pathology (2012) 181(1):278-93. Epub 2012/06/16. doi: 10.1016/j.ajpath.2012.03.017. PubMed PMID: 22698676; PubMed Central PMCID: PMC3388151.
58. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, Lisanti MP. Caveolin- 1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annual review of pathology (2012) 7:423-67. Epub 2011/11/15. doi: 10.1146/annurev pathol-011811-120856. PubMed PMID: 22077552.
59. Queen BL, Tollefsbol TO. Polyphenols and aging. Current aging science (2010) 3(1):34-42. Epub 2010/03/20. PubMed PMID: 20298168; PubMed Central PMCID: PMC2896035.
60. Trichopoulou A. Traditional Mediterranean diet and longevity in the elderly: a review. Public health nutrition (2004) 7(7):943-7. Epub 2004/10/16. PubMed PMID: 15482622.
61. Colomer R, Menendez JA. Mediterranean diet, olive oil and cancer. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2006) 8(1):15-21. Epub 2006/04/25. PubMed PMID: 16632435.
62. Menendez JA, Joven J, Aragones G, Barrajon-Catalan E, Beltran-Debon R, Borras-Linares I, et al. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle (2013) 12(4):555-78. Epub 2013/02/02. doi: 10.4161/cc.23756. PubMed PMID: 23370395; PubMed Central PMCID: PMC3594257.
63. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (New York, NY (2009) 324(5930):1029- 33. Epub 2009/05/23. doi: 10.1126/science.1160809. PubMed PMID: 19460998; PubMed Central PMCID: PMC2849637.
64. Pazolli E, Alspach E, Milczarek A, Prior J, Piwnica-Worms D, Stewart SA. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer research (2012) 72(9):2251-61. Epub 2012/03/17. doi: 10.1158/0008-5472.CAN-11-3386. PubMed PMID: 22422937; PubMed Central PMCID: PMC3605047.
65. Gravina GL, Mancini A, Ranieri G, Di Pasquale B, Marampon F, Di Clemente L, et al. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. International journal of oncology (2013) 42(6):2116-22. Epub 2013/04/17. doi: 10.3892/ijo.2013.1892. PubMed PMID: 23589051.
66. Lewis DA, Travers JB, Machado C, Somani AK, Spandau DF. Reversing the aging stromal phenotype prevents carcinoma initiation. Aging (2011) 3(4):407-16. Epub 2011/04/26. PubMed PMID: 21515933; PubMed Central PMCID: PMC3117456.
67. Kortlever RM, Bernards R. Senescence, wound healing and cancer: the PAI-1 connection. Cell cycle (2006) 5(23):2697-703. Epub 2006/12/19. PubMed PMID: 17172853.
68. Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mechanisms of ageing and development (2005) 126(1):59-69. Epub 2004/12/22. doi: 10.1016/j.mad.2004.09.023. PubMed PMID: 15610763.